Several groups have demonstrated that inhibiting the enzyme dihydroorotate dehydrogenase (DHODH), a rate-limiting step in pyrimidine biosynthesis, unexpectedly and profoundly enforces the terminal differentiation of AML cells, mainly toward neutrophils (26–28). The gene discussed is DHODH; the disease is acute myeloid leukemia.